Research of Pathogenesis and Novel Therapeutics in Arthritis

Arthritis has a high prevalence globally and includes over 100 different types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: Tang, Chih-Hsin
Materyal Türü: Online
Dil:İngilizce
Baskı/Yayın Bilgisi: MDPI - Multidisciplinary Digital Publishing Institute 2021
Konular:
rat
WNT
Online Erişim:33667
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
_version_ 1869526591386681344
author Tang, Chih-Hsin
author_browse Tang, Chih-Hsin
author_facet Tang, Chih-Hsin
author_sort Tang, Chih-Hsin
collection Directory of Open Access Books
description Arthritis has a high prevalence globally and includes over 100 different types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for arthritis patients. This book summarizes and discusses the global picture of the current understanding of arthritis.
format Online
id doab-20.500.12854ir-58295
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-582952024-03-31T13:09:47Z Research of Pathogenesis and Novel Therapeutics in Arthritis Tang, Chih-Hsin R5-920 RM1-950 receptor activator of nuclear factor ?B infliximab tripterine triptolide osteoblast tumor necrosis factor-alpha synovial cell anti-arthritis biosimilars Epstein-Barr virus cytokines SOX9 parathyroid hormone nitric oxide rat etanercept angiogenesis glycosylation mitogen activated protein kinase Th9 lymphocytes rheumatoid arthritis IL-6 clodronate bone erosion mesenchymal stem cells collagen-induced arthritis biological gene expression inflammatory arthritis osteoarthritis fraxinellone nuclear factor kappa B messenger RNA inflammation miRNA disease-modifying adipokines WNT glycoprotein 42 miR-199a-5p proliferation next-generation sequencing collagen osteoarthritis (OA) experimental arthritis bone morphogenetic protein TNF-? computational modeling basic research osteoclast therapeutics certolizumab pegol chondrocytes progenitor cells adjuvant arthritis adalimumab triterpenoid sclareol TNF? fibroblast growth factor 2 antibodies osteoblasts molecular pathology Th17 immunology obesity visfatin articular cartilage autoimmune biomarkers celastrol MAPK disease pathways IL1? arthritis bioinformatics anticitrullinated peptide antibodies drug delivery system antagonists shared epitope pathology SMA- and MAD-related protein small-molecule inhibitor transforming growth factor ? mice golimumab spinal fusion antirheumatic drug early osteoarthritis stem cell rheumatoid factor therapeutic antibody bisphosphonate osteoclastogenesis interleukin spondyloarthropathies clinical translation therapy Traditional Chinese medicine chemokines structure cell signaling microRNA thema EDItEUR::M Medicine and Nursing Arthritis has a high prevalence globally and includes over 100 different types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for arthritis patients. This book summarizes and discusses the global picture of the current understanding of arthritis. 2021-02-12T01:59:33Z 2021-02-12T01:59:33Z 2019-06-26 08:44:06 2019 book 33667 9783038970651 9783038970668 https://directory.doabooks.org/handle/20.500.12854/58295 eng image/jpeg Attribution-NonCommercial-NoDerivatives 4.0 International https://mdpi.com/books/pdfview/book/1327 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-03897-066-8 10.3390/books978-3-03897-066-8 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783038970651 9783038970668 366 open access
spellingShingle R5-920
RM1-950
receptor activator of nuclear factor ?B
infliximab
tripterine
triptolide
osteoblast
tumor necrosis factor-alpha
synovial cell
anti-arthritis
biosimilars
Epstein-Barr virus
cytokines
SOX9
parathyroid hormone
nitric oxide
rat
etanercept
angiogenesis
glycosylation
mitogen activated protein kinase
Th9 lymphocytes
rheumatoid arthritis
IL-6
clodronate
bone erosion
mesenchymal stem cells
collagen-induced arthritis
biological
gene expression
inflammatory arthritis
osteoarthritis
fraxinellone
nuclear factor kappa B
messenger RNA
inflammation
miRNA
disease-modifying
adipokines
WNT
glycoprotein 42
miR-199a-5p
proliferation
next-generation sequencing
collagen
osteoarthritis (OA)
experimental arthritis
bone morphogenetic protein
TNF-?
computational modeling
basic research
osteoclast
therapeutics
certolizumab pegol
chondrocytes
progenitor cells
adjuvant arthritis
adalimumab
triterpenoid
sclareol
TNF?
fibroblast growth factor 2
antibodies
osteoblasts
molecular pathology
Th17
immunology
obesity
visfatin
articular cartilage
autoimmune
biomarkers
celastrol
MAPK
disease pathways
IL1?
arthritis
bioinformatics
anticitrullinated peptide antibodies
drug delivery system
antagonists
shared epitope
pathology
SMA- and MAD-related protein
small-molecule inhibitor
transforming growth factor ?
mice
golimumab
spinal fusion
antirheumatic drug
early osteoarthritis
stem cell
rheumatoid factor
therapeutic antibody
bisphosphonate
osteoclastogenesis
interleukin
spondyloarthropathies
clinical translation
therapy
Traditional Chinese medicine
chemokines
structure
cell signaling
microRNA
thema EDItEUR::M Medicine and Nursing
Tang, Chih-Hsin
Research of Pathogenesis and Novel Therapeutics in Arthritis
title Research of Pathogenesis and Novel Therapeutics in Arthritis
title_full Research of Pathogenesis and Novel Therapeutics in Arthritis
title_fullStr Research of Pathogenesis and Novel Therapeutics in Arthritis
title_full_unstemmed Research of Pathogenesis and Novel Therapeutics in Arthritis
title_short Research of Pathogenesis and Novel Therapeutics in Arthritis
title_sort research of pathogenesis and novel therapeutics in arthritis
topic R5-920
RM1-950
receptor activator of nuclear factor ?B
infliximab
tripterine
triptolide
osteoblast
tumor necrosis factor-alpha
synovial cell
anti-arthritis
biosimilars
Epstein-Barr virus
cytokines
SOX9
parathyroid hormone
nitric oxide
rat
etanercept
angiogenesis
glycosylation
mitogen activated protein kinase
Th9 lymphocytes
rheumatoid arthritis
IL-6
clodronate
bone erosion
mesenchymal stem cells
collagen-induced arthritis
biological
gene expression
inflammatory arthritis
osteoarthritis
fraxinellone
nuclear factor kappa B
messenger RNA
inflammation
miRNA
disease-modifying
adipokines
WNT
glycoprotein 42
miR-199a-5p
proliferation
next-generation sequencing
collagen
osteoarthritis (OA)
experimental arthritis
bone morphogenetic protein
TNF-?
computational modeling
basic research
osteoclast
therapeutics
certolizumab pegol
chondrocytes
progenitor cells
adjuvant arthritis
adalimumab
triterpenoid
sclareol
TNF?
fibroblast growth factor 2
antibodies
osteoblasts
molecular pathology
Th17
immunology
obesity
visfatin
articular cartilage
autoimmune
biomarkers
celastrol
MAPK
disease pathways
IL1?
arthritis
bioinformatics
anticitrullinated peptide antibodies
drug delivery system
antagonists
shared epitope
pathology
SMA- and MAD-related protein
small-molecule inhibitor
transforming growth factor ?
mice
golimumab
spinal fusion
antirheumatic drug
early osteoarthritis
stem cell
rheumatoid factor
therapeutic antibody
bisphosphonate
osteoclastogenesis
interleukin
spondyloarthropathies
clinical translation
therapy
Traditional Chinese medicine
chemokines
structure
cell signaling
microRNA
thema EDItEUR::M Medicine and Nursing
topic_facet R5-920
RM1-950
receptor activator of nuclear factor ?B
infliximab
tripterine
triptolide
osteoblast
tumor necrosis factor-alpha
synovial cell
anti-arthritis
biosimilars
Epstein-Barr virus
cytokines
SOX9
parathyroid hormone
nitric oxide
rat
etanercept
angiogenesis
glycosylation
mitogen activated protein kinase
Th9 lymphocytes
rheumatoid arthritis
IL-6
clodronate
bone erosion
mesenchymal stem cells
collagen-induced arthritis
biological
gene expression
inflammatory arthritis
osteoarthritis
fraxinellone
nuclear factor kappa B
messenger RNA
inflammation
miRNA
disease-modifying
adipokines
WNT
glycoprotein 42
miR-199a-5p
proliferation
next-generation sequencing
collagen
osteoarthritis (OA)
experimental arthritis
bone morphogenetic protein
TNF-?
computational modeling
basic research
osteoclast
therapeutics
certolizumab pegol
chondrocytes
progenitor cells
adjuvant arthritis
adalimumab
triterpenoid
sclareol
TNF?
fibroblast growth factor 2
antibodies
osteoblasts
molecular pathology
Th17
immunology
obesity
visfatin
articular cartilage
autoimmune
biomarkers
celastrol
MAPK
disease pathways
IL1?
arthritis
bioinformatics
anticitrullinated peptide antibodies
drug delivery system
antagonists
shared epitope
pathology
SMA- and MAD-related protein
small-molecule inhibitor
transforming growth factor ?
mice
golimumab
spinal fusion
antirheumatic drug
early osteoarthritis
stem cell
rheumatoid factor
therapeutic antibody
bisphosphonate
osteoclastogenesis
interleukin
spondyloarthropathies
clinical translation
therapy
Traditional Chinese medicine
chemokines
structure
cell signaling
microRNA
thema EDItEUR::M Medicine and Nursing
url 33667
work_keys_str_mv AT tangchihhsin researchofpathogenesisandnoveltherapeuticsinarthritis